Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
SAG Holdings Limited - Ordinary Shares | SAG | Nov 22, 2024 | 2.74 | 0.00 |
Saga Communications A | SGA | Nov 22, 2024 | 13.19 | +4.52 |
Sage Therapeutics | SAGE | Nov 22, 2024 | 5.17 | +6.60 |
Sagimet Biosciences | SGMT | Nov 22, 2024 | 4.76 | +5.78 |
SAI.TECH Global | SAI | Nov 22, 2024 | 0.75 | 0.00 |
Saia | SAIA | Nov 22, 2024 | 541.69 | -1.37 |
SAIHEAT A | SAIH | Nov 22, 2024 | 1.11 | 0.00 |
Salarius Pharmaceuticals | SLRX | Nov 22, 2024 | 1.37 | -6.16 |
Salesforce | CRM | Nov 22, 2024 | 342.02 | +1.86 |
Sally Beauty | SBH | Nov 22, 2024 | 12.97 | 0.00 |
Samfine Creation Group | SFHG | Nov 22, 2024 | 11.70 | 0.00 |
Samsara A | IOT | Nov 22, 2024 | 56.35 | +2.68 |
San Juan Basin Royalty Trust Unit | SJT | Nov 22, 2024 | 4.10 | +1.49 |
Sana Biotechnology | SANA | Nov 22, 2024 | 2.61 | +11.06 |
Sanara MedTech | SMTI | Nov 22, 2024 | 37.70 | +1.02 |
SandRidge Energy | SD | Nov 22, 2024 | 12.11 | +3.06 |
Sandstorm Gold | SAND | Nov 22, 2024 | 5.85 | +0.86 |
Sandy Spring Bancorp | SASR | Nov 22, 2024 | 37.85 | +1.83 |
Sangamo Therapeutics | SGMO | Nov 22, 2024 | 1.88 | -4.08 |
Sangoma Technologies | SANG | Nov 22, 2024 | 6.22 | +2.00 |
Sanmina | SANM | Nov 22, 2024 | 79.41 | -0.14 |
Sanofi ADR | SNY | Nov 22, 2024 | 48.28 | +0.63 |
Santech ADR | STEC | Nov 22, 2024 | 1.04 | -2.80 |
SAP ADR | SAP | Nov 22, 2024 | 236.25 | +0.09 |
Sapiens | SPNS | Nov 22, 2024 | 27.73 | +0.65 |
Saratoga Investment New | SAR | Nov 22, 2024 | 26.07 | +1.52 |
Sarepta Therapeutics | SRPT | Nov 22, 2024 | 114.23 | +3.38 |
Sasol ADR | SSL | Nov 22, 2024 | 5.51 | +0.73 |
Satellogic A | SATL | Nov 22, 2024 | 1.40 | +10.24 |
SatixFy Communications | SATX | Nov 22, 2024 | 0.83 | +1.57 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.